Financial Year |
March 31 2023 |
Monetary Funds |
16,934,939,365.49 |
Held-for-trading Financial Assets |
2,354,945,736.36 |
Notes Receivable |
6,825,301,317.87 |
Accounts Receivable |
567,047,904.88 |
Advances to Suppliers |
514,095,913.66 |
Other Receivables |
270,177,264.48 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,123,762,179.78 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
272,744,930.52 |
Total Current Assets |
29,975,519,128.28 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
116,391,214.89 |
Investment Properties |
87,054,789.04 |
Fixed Assetes |
7,477,759,371.65 |
Under-construction Projects |
803,095,984.50 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
989,658,916.15 |
R&D expenses |
-- |
Goodwill |
3,928,667.24 |
Long-Term Deferred and Prepaid Expenses |
38,244,124.45 |
Deferred Income Tax Assets |
1,763,977,192.06 |
Other Non-Current Assets |
435,415,182.81 |
Sub-Total of Non-Current Assets |
12,397,538,098.12 |
Total Assets |
42,373,057,226.40 |
Short-Term Loans |
79,907,800.00 |
Trading Financial liabilities |
-- |
Notes Payable |
14,420,717.36 |
Accounts Payable |
1,778,521,399.62 |
Accounts Received In Advance |
6,378,942.26 |
Employee Compensation Payable |
524,030,196.33 |
Taxes Payable |
233,897,217.91 |
Interest Payable |
141,297,524.20 |
Dividend Payable |
10,871,091.52 |
Other payables |
538,460,969.72 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,750,234,487.65 |
Other Current Liabilities |
98,749,635.62 |
Sub-Total of Current Liabilities |
7,121,807,540.88 |
Long-term Loans |
1,433,741,537.69 |
Bonds Payable |
2,551,932,700.45 |
Long-Term Accounts Payable |
617,289,476.06 |
Special Payable |
-- |
Estimatied Liabilities |
148,295,861.91 |
Deferred Income Tax Liabilities |
38,276,206.51 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
4,976,329,578.79 |
Total Liabilities |
12,098,137,119.67 |
Paid-In Capital(Or Share Stock) |
5,432,876,672.00 |
Capital Surplus |
40,697,487,615.69 |
Surplus Reserve |
1,939,006,250.16 |
LESS:Treasury Stock |
913,284,740.96 |
Undistributed Profits |
-20,725,885,240.43 |
Minority Stockholder's Interest |
3,438,850,388.34 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,836,069,718.39 |
Owner's Equity(Stockholder's Equity) |
30,274,920,106.73 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
42,373,057,226.40 |